Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.075 USD | +1.30% | -3.08% | +20.12% |
11:15am | Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US | MT |
May. 27 | Global markets live: UBS, Tesla, Nvidia, Apple, Micron... |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.12% | 292M | |
+10.96% | 114B | |
+10.60% | 105B | |
-4.88% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-16.90% | 16.13B | |
+2.21% | 13.75B | |
+31.62% | 11.76B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q1 Revenue $47.5M